LetsGetChecked

Headquartered in Dublin and New York, LetsGetChecked (LGC) offers more than 100 at-home healthcare test kits for fertility, cholesterol, diabetes, thyroid, and Covid-19, among others. It provides the test results online and offers follow-up care through its telehealth and pharmacy offerings.

In the fertility tech space, the company offers two types of finger-prick test kits (a progesterone test and an ovarian reserve test) that allow samples to be gathered at home, later being mailed to the lab for analysis. The progesterone test assesses whether ovulation has occurred, and the ovarian reserve test measures the Anti-Mullerian Hormone (AMH) to indicate the number of a woman’s remaining eggs.

LetsGetChecked acquired the health and diagnostics company BioIQ in May 2022. BioIQ works with employers and health plans to provide health testing solutions such as lab testing, health screening, and vaccination services. The company operates through a nationwide network of labs and served millions of customers as at the date of acquisition. The acquisition expanded LetsGetChecked’s personalized at-home healthcare testing services including lab analysis, affiliated physician support, and prescription fulfillment to BioIQ’s health plans, employers, consumers, and public health partners.

Key customers and partnerships

As of September 2022, LetsGetChecked offered more than 100 at-home wellness and chronic condition tests, delivered over 10 million tests, and partnered with more than 300 business customers in the US, UK, and the EU.

Funding and financials

In June 2021, the company raised USD 150 million in Series D funding led by Casdin Capital, reaching unicorn status with a valuation of over USD 1 billion. The funds were utilized to expand internationally and strengthen its telehealth services, pharmacy capabilities, and at-home testing. In September 2022, the company secured a USD 20 million extension to its Series D round from Morgan Health, bringing the total funding raised to USD 283 million.

The company benefited from the Covid-19 pandemic promoting at-home healthcare and claimed its revenue grew 1,500% YoY owing to the pandemic.